Skip to content
TodayPrism
Updated 2h agoBusiness & Markets

GLP-1 boom pushes pharma companies into wellness and nutraceuticals

Headline by Prism · from 1 report

Pharmaceutical companies are expanding into wellness and nutraceutical products to complement the growing use of GLP-1 weight-loss medications.

1 outlet · 1 report · EnglishOne source so far

The record

Written from the 1 report below. Nothing here is unsourced.

  • Pharmaceutical companies are increasingly acquiring wellness and nutraceutical businesses to support patients taking GLP-1 weight-loss drugs.
  • These medications suppress appetite, leading to concerns about nutritional deficiencies in users.
  • Drugmakers are responding by developing and acquiring supplements, vitamins, and protein products designed to fill these nutritional gaps.
  • This trend reflects a broader strategy by pharmaceutical firms to integrate consumer health offerings alongside their primary weight-management therapies.

What to watch next

  • Launch of Kilitch's GLP-1 drug scheduled for December 2026
  • Further acquisitions by pharmaceutical companies in the wellness and nutraceutical sectors
  • Development of new nutritional products tailored for GLP-1 medication users

Who said what2

Only words found exactly in the article are shown, attributed and linked to the line they came from.

Bhavin Mehta

2 quotes · 1 outlet

  • So we have gone into wellness
    [1]The Hindu BusinessLine2h agoOpen at the quote ↗
    In the article

    Kilitch has also moved into the wellness segment with Royvit, a vitamin and nutritional supplement available in sachet and effervescent tablet formats, said Bhavin Mehta, Whole-time Director of Kilitch Drugs. “ So we have gone into wellness ,” he said, explaining the company’s move. He said the product was developed with GLP-1 users in mind, amid concerns about lower food and nutrient intake among people taking weight-loss medicines. “Nowadays, if people

  • Nowadays, if people are taking semaglutide or other weight-loss medicines, their appetite reduces, and they may require adequate daily intake of proteins, nutrients and vitamins.
    [1]The Hindu BusinessLine2h agoOpen at the quote ↗
    In the article

    gone into wellness,” he said, explaining the company’s move. He said the product was developed with GLP-1 users in mind, amid concerns about lower food and nutrient intake among people taking weight-loss medicines. “ Nowadays, if people are taking semaglutide or other weight-loss medicines, their appetite reduces, and they may require adequate daily intake of proteins, nutrients and vitamins. Based on feedback from doctors, we decided to develop a product to supplement vitamins and nutrients and help meet the daily requirement. Hence, we launched this,” he said. He said feedback from doctors was also behind

Coverage1

1 report
English national1

All filed from India

Named India · Innovcare Lifesciences · Inzpera Healthsciences · Nutritionalab · Wellbeing Nutrition · Bhavin Mehta · Cipla · Kilitch Drugs · Sun Pharmaceutical Industries · USV

Ask this story

Answers cite the reports above, or say they can't.

← Today’s record

GLP-1 boom pushes pharma companies into wellness and nutraceuticals | Prism